Anne M Vangen-Lønne1, Tom Wilsgaard2, Stein Harald Johnsen2, Maja-Lisa Løchen2, Inger Njølstad2, Ellisiv B Mathiesen2. 1. From the Departments of Clinical Medicine (A.M.V.-L., S.H.J., E.B.M.) and Community Medicine (T.W., M.-L.L., I.N.), The Arctic University of Norway, Tromsø; Department of Neurology, Innlandet Hospital Trust, Norway (A.M.V.-L.); and Department of Neurology, University Hospital of North Norway, Tromsø (S.H.J., E.B.M.). am.vanglon@gmail.no. 2. From the Departments of Clinical Medicine (A.M.V.-L., S.H.J., E.B.M.) and Community Medicine (T.W., M.-L.L., I.N.), The Arctic University of Norway, Tromsø; Department of Neurology, Innlandet Hospital Trust, Norway (A.M.V.-L.); and Department of Neurology, University Hospital of North Norway, Tromsø (S.H.J., E.B.M.).
Abstract
BACKGROUND AND PURPOSE: It is proposed that 20% to 40% of the decline in first-ever stroke incidence is attributed to the improvement of risk factor control. We estimated the impact of modifiable cardiovascular risk factors on the changing incidence of ischemic stroke (IS) between 1995 and 2012, using individual person data from repeated surveys in a general population. METHODS: The proportion of the IS incidence decline explained by change in each risk factor over time was estimated from 1995 to 2012 by Poisson regression among 26 329 participants who attended the fourth Tromsø survey in 1994 to 1995. Hazard ratios for IS were estimated with Cox proportional hazards regression among 27 936 participants who attended at least 1 of the Tromsø surveys in 1994 to 1995, 2001, or 2007 to 2008. Age- and sex-adjusted means or prevalences of risk factors over time were estimated by generalized estimating equations. RESULTS: There were 1226 first-ever IS during 367 636 person-years of follow-up. Changes in cardiovascular risk factors accounted for 57% of the decrease in IS incidence from 1995 to 2012. The most important contributors were decreasing mean systolic blood pressure and smoking prevalence, accounting for 26% and 17% of the observed decline, respectively. Conversely, increasing diabetes mellitus prevalence contributed negatively to the declining IS incidence. CONCLUSIONS: Changes in cardiovascular risk factors explained 57% of the decrease in IS incidence from 1995 to 2012. Reduction in systolic blood pressure and prevalence of smoking were the most important contributors.
BACKGROUND AND PURPOSE: It is proposed that 20% to 40% of the decline in first-ever stroke incidence is attributed to the improvement of risk factor control. We estimated the impact of modifiable cardiovascular risk factors on the changing incidence of ischemic stroke (IS) between 1995 and 2012, using individual person data from repeated surveys in a general population. METHODS: The proportion of the IS incidence decline explained by change in each risk factor over time was estimated from 1995 to 2012 by Poisson regression among 26 329 participants who attended the fourth Tromsø survey in 1994 to 1995. Hazard ratios for IS were estimated with Cox proportional hazards regression among 27 936 participants who attended at least 1 of the Tromsø surveys in 1994 to 1995, 2001, or 2007 to 2008. Age- and sex-adjusted means or prevalences of risk factors over time were estimated by generalized estimating equations. RESULTS: There were 1226 first-ever IS during 367 636 person-years of follow-up. Changes in cardiovascular risk factors accounted for 57% of the decrease in IS incidence from 1995 to 2012. The most important contributors were decreasing mean systolic blood pressure and smoking prevalence, accounting for 26% and 17% of the observed decline, respectively. Conversely, increasing diabetes mellitus prevalence contributed negatively to the declining IS incidence. CONCLUSIONS: Changes in cardiovascular risk factors explained 57% of the decrease in IS incidence from 1995 to 2012. Reduction in systolic blood pressure and prevalence of smoking were the most important contributors.
Authors: Magnus S Edvardsen; Kristian Hindberg; Ellen-Sofie Hansen; Vânia M Morelli; Thor Ueland; Pål Aukrust; Sigrid K Brækkan; Line H Evensen; John-Bjarne Hansen Journal: Blood Adv Date: 2021-01-12
Authors: Fadar Oliver Otite; Nicholas Liaw; Priyank Khandelwal; Amer M Malik; Jose G Romano; Tatjana Rundek; Ralph L Sacco; Seemant Chaturvedi Journal: Neurology Date: 2017-10-11 Impact factor: 9.910
Authors: Thomas G Brott; David Calvet; George Howard; John Gregson; Ale Algra; Jean-Pierre Becquemin; Gert J de Borst; Richard Bulbulia; Hans-Henning Eckstein; Gustav Fraedrich; Jacoba P Greving; Alison Halliday; Jeroen Hendrikse; Olav Jansen; Jenifer H Voeks; Peter A Ringleb; Jean-Louis Mas; Martin M Brown; Leo H Bonati Journal: Lancet Neurol Date: 2019-02-06 Impact factor: 44.182
Authors: Susanna R A Siri; Bent M Eliassen; Ann R Broderstad; Marita Melhus; Vilde L Michalsen; Bjarne K Jacobsen; Luke J Burchill; Tonje Braaten Journal: Open Heart Date: 2020-05